中源協和(600645.SH)簽署合作協議書 變更中源協和生命醫學獎設立主體
格隆匯10月15日丨中源協和(600645.SH)公佈,公司十屆三次臨時董事會會議審議通過《關於變更中源協和生命醫學獎設立主體暨關聯交易的議案》,同意自第五屆中源協和生命醫學獎開始由公司獨自出資承辦,每年總體承辦費用不超過400萬元。
根據上述董事會決議,2020年10月15日,公司與中國科學院大學簽署《關於出資承辦“中源協和生命醫學獎”之合作協議書》,由公司與中國科學院大學繼續沿用“中源協和生命醫學獎”冠名承辦該獎項,並由公司出資支持,每年出資不超過人民幣400萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.